Announced Tue, 19 May · 18:54 IST

Submission of Revised Audited Financial Results for the Quarter and year Ended 31.03.2026 for Board Meeting held on 19.05.2026

Pat NegativeResults RestatedEmphasis Of MatterNegative Operating CashflowGoing ConcernContingent Liabilities IncreasedResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.4%1-day move
₹14.08
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.4-13.8-18.1-22.2-29.6-44.2-44.5-52.1
Up moveDown movePending
AI summary

Gayatri BioOrganics has resubmitted its audited financial results for FY26 correcting typographical errors, stating no impact on actual financials. The company reported a net loss of Rs 111.18 lakh for FY26, a 53% increase from Rs 72.65 lakh loss in FY25. Quarterly loss for Q4 FY26 was Rs 42.05 lakh. Revenue from operations appears minimal at around Rs 2 lakh for the quarter. The company has significant negative other equity of Rs 11,579.31 lakh. Operating cash outflows were Rs 73.54 lakh for the year. The auditors issued an unmodified opinion but included an Emphasis of Matter drawing attention to certain notes. The financial statements were prepared on a going concern basis supported by a comfort letter from promoters.

Likely market impact

The company continues to burn cash with widening losses and negative equity, indicating severe financial distress. Shareholders should note the reliance on promoter support for going concern assumptions and multiple disputed statutory liabilities totaling over Rs 25 crore.